GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.3% | +0.0% | +6.4% | +112.9% | +13.6% | +3.3% | +0.9% | -6.7% | +8.4% | +7.2% | -2.1% | +7.1% | +16.5% | +0.1% | -3.5% | -3.5% | +0.3% | -13.2% | +4.0% | +16.6% | +8.2% | +2.1% | +9.5% | -27.8% | +1.4% | +18.7% | +3.4% | +3.5% | +4.1% | |
| – | – | – | +180.5% | -8.6% | +12.1% | +3.8% | -1.5% | -4.0% | +9.3% | +5.2% | +4.0% | +23.1% | +15.0% | +7.0% | -3.2% | +3.6% | +8.3% | -14.7% | +20.9% | +4.9% | +11.3% | -1.0% | +15.8% | -33.2% | +3.0% | +17.0% | -10.4% | +5.6% | -0.3% | |
| – | -4.3% | -19.3% | -35.4% | +239.7% | +14.0% | +3.2% | +1.6% | -7.4% | +8.2% | +7.8% | -3.7% | +2.3% | +17.0% | -2.4% | -3.7% | -6.2% | -3.2% | -12.5% | -3.9% | +23.4% | +6.7% | +3.7% | +6.4% | -25.0% | +0.7% | +19.6% | +10.1% | +2.6% | +5.9% | |
| – | -1.1% | +1.3% | +9.1% | +99.1% | +1.4% | +13.2% | -3.9% | +4.2% | +8.0% | +10.2% | -6.2% | +13.6% | +11.5% | +8.5% | -10.1% | -0.7% | -1.4% | -12.1% | +3.2% | +1.9% | +23.4% | -13.0% | +17.3% | +4.9% | +4.7% | +9.3% | +13.4% | +2.9% | +17.6% | |
| – | – | – | – | – | -46.3% | +7.7% | -5.8% | -4.9% | +0.7% | +0.1% | -5.9% | +12.2% | +25.3% | +32.9% | -33.2% | +3.3% | -3.5% | -2.8% | +12.0% | +1.5% | +3.3% | +2.5% | +15.0% | -34.8% | -4.9% | +18.4% | +12.1% | +17.4% | -17.5% | |
| – | -1.0% | -27.2% | -59.2% | +513.2% | +6.4% | +10.6% | -5.1% | -6.0% | +67.5% | -37.1% | -7.8% | +12.6% | +16.4% | +33.0% | -28.6% | -6.1% | -2.8% | +11.0% | -60.7% | +237.0% | -1.5% | -4.2% | -1.1% | -30.0% | +16.6% | +9.5% | +12.6% | +21.9% | -16.4% | |
| – | -9.9% | -4.9% | -2.2% | +80.2% | +29.1% | -9.0% | +15.0% | -17.6% | +30.5% | +4.7% | +10.5% | -10.1% | +18.0% | -55.1% | +106.4% | -6.5% | -3.7% | -48.8% | +187.0% | -74.8% | +57.3% | +34.2% | +27.0% | -14.1% | -27.1% | +47.6% | +4.8% | -40.4% | +107.4% | |
| – | -17.8% | -11.0% | +2.0% | +53.9% | +262.4% | -82.1% | -21.8% | +124.8% | +24.6% | -22.0% | -10.6% | +167.7% | -7.1% | -2.3% | -3.0% | -1.0% | +4.4% | -9.2% | +8.7% | -2.8% | -0.3% | +1.3% | +22.6% | -2.2% | -12.1% | +9.1% | -9.4% | -15.2% | +4.5% | |
| – | -9.4% | -0.6% | -3.6% | +134.1% | +0.9% | -9.5% | +14.8% | -13.8% | +30.3% | +5.2% | +0.9% | -11.6% | +18.5% | -60.0% | +143.8% | -14.3% | +0.7% | -55.3% | +254.6% | -81.6% | +81.8% | +36.2% | +29.6% | -16.9% | -30.4% | +56.4% | +7.7% | -42.7% | +112.9% | |
| – | -12.2% | -0.5% | -8.5% | +134.2% | -5.5% | -11.5% | +18.9% | -3.6% | +20.7% | +9.1% | -2.3% | -9.6% | +14.1% | -41.3% | +71.8% | -14.2% | -47.0% | -86.6% | +1,472.3% | -59.3% | +54.6% | -44.4% | +26.4% | -93.0% | +23.9% | +751.8% | +6.9% | -30.4% | +111.4% | |
| – | -7.4% | -0.8% | -1.4% | +129.8% | -25.5% | +26.9% | +13.8% | -12.8% | +20.0% | +14.9% | -3.1% | -11.8% | +20.2% | -70.5% | +222.0% | -14.5% | +20.8% | -49.3% | +205.6% | -89.2% | +68.0% | +136.5% | +28.2% | +23.8% | -23.7% | +241.1% | -67.1% | -47.7% | +122.0% | |
| – | -10.0% | -1.7% | -0.7% | +121.5% | -2.7% | -5.5% | +10.8% | -8.7% | -80.8% | +591.4% | +5.3% | -5.3% | +17.2% | -45.1% | +75.7% | -10.9% | 0.0% | -41.4% | +150.1% | -65.6% | +39.6% | +18.9% | +25.4% | -12.5% | -19.6% | +32.6% | +5.6% | -26.6% | +56.0% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.